Search research articles
Contact Us
Filters
Showing results (81-90 of 113) with videos related to
Page
of 12
Sort By:
Haematologica
|
September 8, 2009
Two new beta-thalassemia deletions compromising prenatal diagnosis in an Italian and a Turkish couple seeking prevention
Marion Phylipsen, Antonio Amato, Maria Pia Cappabianca, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance
|
January 27, 2012
Effects of combined deferiprone with deferoxamine on right ventricular function in thalassaemia major
Francisco Alpendurada, Gill C Smith, John-Paul Carpenter, et al.
European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology
|
February 1, 2011
Clinical management of cardiovascular complications in patients with thalassaemia major: a large observational multicenter study
Giorgio Derchi, Francesco Formisano, Manuela Balocco, et al.
Molecular Pharmacology
|
August 2, 2007
Identification of two new synthetic histone deacetylase inhibitors that modulate globin gene expression in erythroid cells from healthy donors and patients with thalassemia
Antonello Mai, Katija Jelicic, Dante Rotili, et al.
Circulation
|
October 2, 2013
Prevalence and risk factors for pulmonary arterial hypertension in a large group of β-thalassemia patients using right heart catheterization: a Webthal study
Giorgio Derchi, Renzo Galanello, Patrizio Bina, et al.
British Journal of Haematology
|
July 9, 2002
The safety and effectiveness of deferiprone in a large-scale, 3-year study in Italian patients
Adriana Ceci, Paola Baiardi, Mariagrazia Felisi, et al.
Blood
|
December 15, 2005
Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis
Dudley J Pennell, Vasili Berdoukas, Markissia Karagiorga, et al.
Parkinsonism & Related Disorders
|
March 26, 2014
Efficacy and safety of deferiprone for the treatment of pantothenate kinase-associated neurodegeneration (PKAN) and neurodegeneration with brain iron accumulation (NBIA): results from a four years follow-up
Giovanni Cossu, Giovanni Abbruzzese, Gildo Matta, et al.
Haematologica
|
March 7, 2014
A decisional algorithm to start iron chelation in patients with beta thalassemia
Fabrice Danjou, Zvi Ioav Cabantchik, Raffaella Origa, et al.
Journal of Clinical Pharmacology
|
February 19, 2008
Effect of food, type of food, and time of food intake on deferasirox bioavailability: recommendations for an optimal deferasirox administration regimen
Renzo Galanello, Antonio Piga, Maria Domenica Cappellini, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 113) with videos related to
Sort By:
Page
of 12
Haematologica
|
September 8, 2009
Two new beta-thalassemia deletions compromising prenatal diagnosis in an Italian and a Turkish couple seeking prevention
Marion Phylipsen, Antonio Amato, Maria Pia Cappabianca, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance
|
January 27, 2012
Effects of combined deferiprone with deferoxamine on right ventricular function in thalassaemia major
Francisco Alpendurada, Gill C Smith, John-Paul Carpenter, et al.
European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology
|
February 1, 2011
Clinical management of cardiovascular complications in patients with thalassaemia major: a large observational multicenter study
Giorgio Derchi, Francesco Formisano, Manuela Balocco, et al.
Molecular Pharmacology
|
August 2, 2007
Identification of two new synthetic histone deacetylase inhibitors that modulate globin gene expression in erythroid cells from healthy donors and patients with thalassemia
Antonello Mai, Katija Jelicic, Dante Rotili, et al.
Circulation
|
October 2, 2013
Prevalence and risk factors for pulmonary arterial hypertension in a large group of β-thalassemia patients using right heart catheterization: a Webthal study
Giorgio Derchi, Renzo Galanello, Patrizio Bina, et al.
British Journal of Haematology
|
July 9, 2002
The safety and effectiveness of deferiprone in a large-scale, 3-year study in Italian patients
Adriana Ceci, Paola Baiardi, Mariagrazia Felisi, et al.
Blood
|
December 15, 2005
Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis
Dudley J Pennell, Vasili Berdoukas, Markissia Karagiorga, et al.
Parkinsonism & Related Disorders
|
March 26, 2014
Efficacy and safety of deferiprone for the treatment of pantothenate kinase-associated neurodegeneration (PKAN) and neurodegeneration with brain iron accumulation (NBIA): results from a four years follow-up
Giovanni Cossu, Giovanni Abbruzzese, Gildo Matta, et al.
Haematologica
|
March 7, 2014
A decisional algorithm to start iron chelation in patients with beta thalassemia
Fabrice Danjou, Zvi Ioav Cabantchik, Raffaella Origa, et al.
Journal of Clinical Pharmacology
|
February 19, 2008
Effect of food, type of food, and time of food intake on deferasirox bioavailability: recommendations for an optimal deferasirox administration regimen
Renzo Galanello, Antonio Piga, Maria Domenica Cappellini, et al.
Page
of 12